Top 5 Health Care Stocks That May Crash This Month
Portfolio Pulse from Lisa Levin
The article lists the top 5 overbought health care stocks that may crash this month, based on their RSI values. The stocks mentioned are Zura Bio Limited (ZURA), Valneva SE (VALN), Biohaven Ltd. (BHVN), Immatics N.V. (IMTX), and Nautilus Biotechnology, Inc. (NAUT).
June 22, 2023 | 11:32 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Biohaven Ltd. is considered overbought with an RSI value of 71.16. The stock recently fell 3.7% to close at $22.94.
BHVN's high RSI value indicates that the stock is overbought and may experience a short-term price decline. The recent 3.7% drop in share price supports this analysis.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Immatics N.V. is considered overbought with an RSI value of 73.25. The stock recently fell 2.4% to close at $12.39.
IMTX's high RSI value indicates that the stock is overbought and may experience a short-term price decline. The recent 2.4% drop in share price supports this analysis.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Nautilus Biotechnology, Inc. is considered overbought with an RSI value of 80.42. The stock recently fell 2.2% to settle at $4.42.
NAUT's high RSI value indicates that the stock is overbought and may experience a short-term price decline. The recent 2.2% drop in share price supports this analysis.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Valneva SE is considered overbought with an RSI value of 75.36. The stock recently fell 4% to close at $16.29.
VALN's high RSI value indicates that the stock is overbought and may experience a short-term price decline. The recent 4% drop in share price supports this analysis.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Zura Bio Limited is considered overbought with an RSI value of 70.91. The stock recently fell 9.2% to close at $11.62.
ZURA's high RSI value indicates that the stock is overbought and may experience a short-term price decline. The recent 9.2% drop in share price supports this analysis.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100